| Literature DB >> 33920947 |
Tatjana Milenkovic1,2, Nadica Bozhinovska3, Djuro Macut4, Jelica Bjekic-Macut5, Dario Rahelic6,7,8, Zelija Velija Asimi9,10, Azra Burekovic11,12.
Abstract
For the past 80 years, the effect of the Mediterranean diet on overall health has been a constant topic of interest among medical and scientific researchers. Parallel with the persistent global rise of cases of type 2 diabetes, many studies conducted in the past 20 years have shown the benefits of the Mediterranean lifestyle for people with, or at risk of developing, type 2 diabetes mellitus. However, despite the large body of evidence, concerns exist amongst scientists regarding the reliability of the data related to this topic. This review offers a glimpse of the onset of the Mediterranean diet and follows its significant impact on the prevention and treatment of type 2 diabetes. There is a constant rise in type 2 diabetes cases on the Balkan Peninsula and North Macedonia in particular. Having in mind that North Macedonia, as well as most of the countries on the Balkans have low to middle income, there is a need for a certain affordable dietary pattern to ameliorate the rise in diabetes incidence, as well as improve the glycemic control. We did a review based on the available literature regarding Mediterranean diet and people with or at risk of developing type 2 diabetes mellitus, its effects on glycemic control, lipid profile and metabolic outcome.Entities:
Keywords: Mediterranean diet; insulin resistance; obesity; prediabetes; type 2 diabetes mellitus
Year: 2021 PMID: 33920947 PMCID: PMC8071242 DOI: 10.3390/nu13041307
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1The initial concept for Mediterranean diet pyramid. In 1993, Oldways created the Mediterranean Diet Pyramid—in partnership with the Harvard School of Public Health and the World Health Organization (WHO).
Figure 2Flow diagram of literature search to identify Meta-Analysis and Systematic reviews evaluating the effect of Mediterranean diet on glycemic control in type 2 diabetes mellitus and diabetes prevention.
Systematic reviews and meta-analysis of the association between the Mediterranean diet and type 2 diabetes (T2D) 2013–2020.
| Author, Year of Publication, Type of Study, Reference | Intervention, Participants | Evaluation, Follow Up | Results/Conclusion |
|---|---|---|---|
| Ajala, O. 2013, 20 RCTs [ | Low carbohydrate, Low GI, MedDiet, High protein diet Adults with type 2 diabetes or obesity | HbA1c Weight loss, >6 months | All diets improved glycemic parameters (glycated hemoglobin reductions of −0.12% LC ( |
| Carter, P. 2014, SR, MA 8 RCTs, [ | MedDiet, Paleo diet, Control diet Overweight and/or high cardiovascular risk and/or type 2 diabetes | Glycemic control, HbA1c, Insulin, 2–12 months | MedDiet superior compared to the control group, except when compared to the paleo diet. None of the diets proved preferable regarding the basal glucose levels. |
| Koloverou, E. 2014, SR, MA 1 RCT, 9 prospective studies [ | MedDiet, Control diet Healthy adults with or without CV/T2D | Incidence of type 2 diabetes, 3.5–14 years | Higher adherence to the MedDiet was associated with 23% reduced risk of developing type 2 diabetes (combined relative risk for upper versus lowest available centile: 0.77; 95% CI: 0.66, 0.89) |
| Esposito, K. 2014, MA 8 prospective studies, 30 cohorts. [ | MedDiet, Dietary Approach to Stop Hypertension (DASH) | Incidence of type 2 diabetes, 3.2–23 years | Both diets presented themselves as a healthy dietary pattern, however comparison between MedDiet and. DASH showed no changes in incidence of type 2 diabetes. |
| Emadian, A. 2015, SR 11 RCTs [ | MedDiet, Vegan diet, Low glycemic index diet Overweight adults and type 2 diabetes | Glycemic control, HbA1c, >6 months | All diet groups resulted beneficial, with improved overall glycemic control by reduction of HbA1c levels. |
| Esposito, K. 2015, SR 8 MA, 5 RCTs [ | MedDiet Control diet Adults with type 2 diabetes or at risk | Incidence of type 2 diabetes Glycemic control, >6 months | MedDiet improves glycemic control by reducing HbA1c 0.3–0.47% compared with low-fat diet. MedDiet has a significant reduction of incidence of future type 2 diabetes ranging from 19% up to 23% |
| Huo, R. 2015, MA 9 RCTs [ | MedDiet Adults with type 2 diabetes | Glycemic control. HbA1c, insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA), 1 month–4 years | The MedDiet group had a significant reduction of HbA1c levels (MD−0.30; 95% CI −0.46, −0.14), glucose levels (MD −0.72 mmol/L; CI −1.24, −0.21), and baseline insulin levels (MD −0.55 μU/mL; CI −0.81, −0.29). |
| Schwingshackl, L. 2015, SR, MA 1 RCT, 8 prospective studies [ | MedDiet Healthy adults or with CV risk factors | Incidence of type 2 diabetes, 3.2–20 years | Adherence to MedDiet inversely associated with a decrease in T2D incidence (high vs. low. RR: 0.81; 95% CI 0.73, 0.90, |
| Jannasch, F. 2017, SLR, MA 48 articles compromising 16 cohorts/ACRs [ | MedDiet, DASH, Alternate Healthy Eating Index (AHEI) | Incidence of type 2 diabetes, 4.1–23 years | Adherence to MedDiet (RR quantiles: 0.87; 95% CI: 0.82, 0.93), DASH (RR: 0.81; 95% CI: 0.72, 0.92), and AHEI (RR: 0.79; 95% CI: 0.69, 0.90) associated with a significant risk reduction of type 2 diabetes |
| Martinez-Lacoba, R. 2018, SMR 9 SR, 24 MA [ | MedDiet Adults | Diet adherence, obesity, body weight type 2 diabetes, >6 months | In summary, a MedDiet pattern may help to prevent and manage type 2 diabetes. |
| Schwingshackl, K. 2018, SR, MA 56 RCTs [ | Low-fat diet or vegan, MedDiet, LC, paleolithic hyperprotein diet Adults with T2D | Glycemic control HbA1c Weight change, 3–48 months | The MedDiet overall superior when compared to the other dietary approaches, by reducing the HbA1c (80%) and reducing the fasting plasma glucose (88%). |
| Zheng M. 2018 SR, 6 RCTs [ | Modified MedDiet Adults with obesity | Glycemic control HbA1c, >3 months | Low-CHO MedDiet and MedDiet using virgin olive oil had a positive impact on the prevention of overweight patients within T2D |
| Becerra-Tomas, N. 2019, SR, MA 3 RCTs, 38 cohorts, [ | MedDiet Adults with type 2 diabetes | CVD incidence, myocardial infarction, CVD mortality, coronary heart disease incidence, >6 months | Beneficial effect on total CVD incidence (RR: 0.62; 95% CI: 0.50, 0.78) and total myocardial infarction (MI) incidence (RR: 0.65; 95% CI: 0.49, 0.88). Highest versus lowest categories of MedDiet adherence, revealed an inverse association with total CVD mortality (RR: 0.79; 95% CI: 0.77, 0.82), coronary heart disease (CHD) incidence (RR: 0.73; 95% CI: 0.62, 0.86), CHD mortality (RR: 0.83; 95% CI: 0.75, 0.92), stroke incidence (RR: 0.80; 95% CI: 0.71, 0.90), stroke mortality (RR: 0.87; 95% CI: 0.80, 0.96) and MI incidence (RR: 0.73; 95% CI: 0.61, 0.88). |
MedDiet = Mediterranean diet, GI = glycemic index, LC = low carb, DASH = dietary approach to stop hypertension, AHEI = alternate healthy eating index, CHO = carbohydrate CVD = cardiovascular disease, RR = risk ratio, CHD = coronary heart disease, MI = Myocardial infarction, HbA1c = glycated hemoglobin A1c, MD = mean difference, MA = meta-analysis, SR = structured review, RCT = randomized control trial; SMR = systematic meta-review.
Figure 3The foundation of the Mediterranean diet based on the original recommendation created by Oldways in partnership with the Harvard School of Public Health and the World Health Organization.
Figure 4Mediterranean diet vs. Insulin resistance, possible mechanisms.